CLINICAL TRIALS
Maximizing the success of analgesic clinical trials with
tailored QST Solutions
Why QST?
-
Phenotyping patients based on underlying pain mechanisms
-
Secondary outcome measures
-
Safety outcome measures
​
“… the European Medicines Agency (EMA) has recently acknowledged […] that sensory profiling and subgrouping […] is an adequate stratification tool for determining specific sensory phenotypes of patients…” (EMA 2016, Baron et al., 2017)
Early design phase support including research and guidelines
Recommendations for advanced QST test batteries and QST endpoints
Streamlined, plug & play technologies with easy setup and operation
Customized software and reports for a program/trial-specific protocol and needs
Multi-layer training approach, including IM materials, trainings at sites, webinars and more
Ongoing, comprehensive support covering all elements of QST performance, monitoring and protocol execution